Serum hypoadiponectinemia and hyperrestinemia independently links insulin resistance to type 2 diabetes (T2DM) and metabolic syndrome (MS).
developing T2DM
10 . It is also the most unifying parameter to characterize the pathophysiology of the MS 1 . Thus, the investigation of the interaction effect of adiponectin and resistin in aetiological linking insulin resistance with T2DM and MS is looking forward. In addition, the modification of the existing insulin resistance indexes by taking into account the interaction effect of adiponectin and resistin merit a potential investigation. It hopefully to identify those with undiagnosed T2DM and MS due to insulin resistance in order to provide early treatment and prevent or delay the onset of long-term complications such as cardiovascular risk.
Adiponectin (also known as Acrp30, AdipoQ, GBP28, and ApM1) is a polypeptide hormone with molecular weight 30kDa (244 amino acids) which modulates a number of metabolic processes, including regulates energy homeostasis as well as glucose and lipid metabolism 11, 12 . It is also a potent insulin sensitizer in muscle and liver 12 . It is exclusively secreted from adipose tissue into the bloodstream and is very abundant in plasma relative to many hormones which representing 0.01% of blood circulating proteins 13, 14 . The hormone plays a principal role in the suppression of the metabolic derangements that may result in insulin resistance, type 2 diabetes, metabolic syndrome and cardiovascular diseases 7, 10, 11, 12, 13, 15 .
Resistin is also known as "serine/cysteine-rich adipocyte-Specific Secretory
Factor" (ADSF and FIZZ3) 16 . It is a putative adipocyte-derived signalling polypeptide hormone with molecular weight 12.5kDa and the length is 108 amino acids in human 16 .
It acts as a pathogenic factor contributing to insulin resistance by antagonizes insulin action, thereby increasing gluconeogenesis and impaired hepatic glucose uptake 17, 18, 19 .
In contrast with adiponectin, resistin has low circulating levels 16 . However, the blood circulating levels of resistin had been shown up-regulated in subjects with insulin resistance, type 2 diabetes, metabolic syndrome and cardiovascular diseases 8,9,20,21,22,23 .
The novel adiponectin-resistin (AR) index. Experimental results showed fasting serum adiponectin (A 0 ) and resistin (R 0 ) levels were strongly correlated with insulin resistance indexes and risk factors (Tables 1-3) . Besides, serum hypoadiponectinemia and hyperresistinemia were significantly associated with T2DM
and MS susceptibility ( Fig. 1-2 ). Therefore,
Since, fasting serum adiponectin (A 0 ) and resistin (R 0 ) levels were significantly negative correlated. Thus, (1) and (2) values are unifying by a multiplication as following
Then (3) is logarithmically transformed for normalization,
Lastly, a numerical constant 1 added to the (4) to get a positive integer of the AR index
Note: R 0 = fasting serum resistin levels in ng/mL; A 0 = fasting serum adiponectin levels in µg/mL.
The novel adiponectin-resistin (AR) index showed stronger association (df=5; F=51.154; P<0.001) with type 2 diabetes (T2DM) and metabolic syndrome (MS) susceptibility rather than the serum adiponectin (df=5; F=15.680; P<0.001) and resistin (df=5; F=40.648; P<0.001) levels alone ( Fig. 1-3 ). The value of the AR index was the lowest for the control subjects followed by the subjects with MS and T2DM. However, the value of the AR index reached the peak when T2DM concurrently with MS. In addition, the AR index showed stronger correlation with insulin resistance (IR) indexes and risk factors particularly the serum insulin, plasma glucose and whole blood HbA1C levels rather than the serum adiponectin and resistin levels alone (Tables 1-3 ). This indicated that the AR index very strongly links insulin resistance to T2DM and MS rather than the serum adiponectin and resistin levels alone.
The most plausible explanation for the interaction effect of adiponectin and resistin in linking insulin resistance with type 2 diabetes and metabolic syndrome is the overall multimeric assembly of the resistin is similar to that of adiponectin 24 . The comparable domain architecture of these two adipocyte-specific hormones, despite diametrically opposed physiological effects, suggest a common regulatory mechanisms for the glucose and lipid homeostasis as well as insulin signalling pathway 24 .
Serum hypoadiponectinemia and hyperresistinemia probably coupling to mediate the dephosphorylation and deactivation of adenosine 5'-monophosphateactivated protein kinase (AMPK) both in muscle and liver with up-regulated gene expression of the gluconeogenic enzymes 11, 25, 26 . This resulting impaired in muscle free fatty acids oxidation and hepatic glucose uptake, dephosphorylation of coenzyme A carboxylase (ACC), increased of gluconeogenesis and glycogenolysis in the liver which eventually lead to free fatty acids and glucose levels in vivo inclined 7,11,24 .
Furthermore, the transcription of peroxisome proliferator-activated receptor α (PPARα) might further down regulated by coupling the serum hypoadiponectinemia and hyperresistinemia 27, 28 . This lead to decrease the levels of molecules involved in free fatty acid transport and energy dissipation which eventually decreased the free fatty acids oxidation 11,27,28 . Up-regulated of resistin followed by down-regulated of PPARγ had been showed to inhibit adipocyte differentiation which lead to the reduction of the serum adiponectin levels dramatically 29 . Therefore, the interaction effect of adiponectin and resistin showed greater impact in the regulation of glucose and lipid homoeostasis rather than adiponectin and resistin alone. A simple schematic of the possible unifying mechanism of adiponectin and resistin in linking insulin resistance with type 2 diabetes and metabolic syndrome was proposed as shown in the Supplementary Figure S1 .
However, the complete mechanisms behind the interaction effect of the adiponectin and resistin on modulating steps in the regulation of energy, glucose and lipid metabolisms merit further investigation.
The novel insulin resistance (IR AR ) index. Experimental results showed the QUICKI index had the most stongest correlation with the adiponectin-resistin (AR) index among the existing insulin resistance indexes (Table 3) . Therefore, the QUICKI index was chosen for a novel insulin resistance index formulation by taking into account the AR index.
Since, the values of QUICKI and AR indexes were significantly negative correlated (Table 3) . Therefore, (5) and (6) are unifying by a multiplicative inverse as following (7) Lastly, (7) is simplify to become a finalized IR AR index as following
Note: I 0 = fasting serum insulin levels in µU/mL; G 0 = fasting serum glucose levels in mg/dL; R 0 = fasting serum resistin levels in ng/mL; A 0 = fasting serum adiponectin levels in µg/mL.
The novel IR AR index showed higher sensitivity of the insulin resistance (IR) assessment in subjects with type 2 diabetes (T2DM) and metabolic syndrome (MS) compared to the other existing IR indexes (Table 4) . Besides, the subjects with T2DM
and MS showed higher values of the IR AR index compared to the control subjects (Fig.   4 ). This indicated that the insulin resistance is predisposing to T2DM and MS susceptibility. In addition, the severity of the insulin resistance using the IR AR index reached the peak when T2DM concurrently with MS (Fig. 4) . Therefore, this indicated that the insulin resistance is play a principle role in predisposing T2DM to MS which trigger the developing of the diabetic complications 4,5 .
These might be explained by the interaction of adiponectin and resistin on modulating steps in the insulin-signalling pathway and inducing insulin resistance 6,9,11,12,22 . Serum hypoadiponectinemia and hyperrestinemia antagonizes insulin signalling via inhibition of the insulin-induced phosphorylation of Akt independent of AMPK pathway, thereby increasing gluconeogenesis and hepatic glucose output 9,11,18,26,30 . The recent study showed it occurred by stimulated expression of glucose-6-phosphate (G6Pase), phosphoenolphyruvate carboxykinase (PEPCK), and suppressor of cytokine signalling 3 (SOC-3), repressed the expressions of insulin receptor substrate 2 (IRS-2) and glucose transporter 2 (GLUT2) 9,31 . Therefore, the coupling of serum hypoadiponectinemia and hyperresistinemia showed stronger induction of insulin resistance rather than serum hypoadiponectinemia and hyperresistinemia alone.
However, these study just a preliminary evaluation for the sensitivity and specificity of the novel insulin resistance (IR AR ) index. For the validation purposes, the euglycemic hyperinsulinemic clamp technique should be used instead as a gold standard index of insulin resistance to evaluate the sensitivity and specificity of the IR AR index in the assessment of insulin resistance. Therefore, the potential of the novel IR AR index as an alternatif useful index for insulin resistance assessment in general population merit further investigation.
As a conclusion, the novel adiponectin-resistin (AR) index showed stronger association in linking insulin resistance with type 2 diabetes (T2DM) and metabolic syndrome (MS) rather than the serum adiponectin and resistin levels alone. Meanwhile, the novel insulin resistance (IR AR ) index is a potent useful index of insulin sensitivity in subjects with T2DM and MS.
Methods Summary
The subjects classify into three main groups included controls, type 2 diabetes mellitus Total cholesterol (mmol/L)
Glucose (mmol/L) (B) HbA1C (%) (B) Insulin (µU/mL)
Adiponectin (µg/mL) NA NA NA NA For descriptive purposes, the sign of correlation coefficient (+/-) are presented using untransformed variables. For hypothesis testing purposes, the values of correlation coefficient (r) is presented using transformed variables. Skewed variables or outliers dealing by using Johnson transformation (J) [1] or Box-Cox Power Transformation (B) [1] . Proceed with non-parametric test for skewed variables and/or if the outliers keep emerging after the data transformation. ra = Pearson Product Moment Correlation Coefficient (P)
[2] / Spearman's Rho Rank Correlation Coefficient (S) [2] rb = Partial Correlation Coefficient using 10,000 Stratified Bootstrap Samples with Bias Corrected and Accelerated 95% CI [2] (multiple testing bias corrections with controlling for covariate ages and stratified ethnics, T2DM and MS status) rc = Multiple Correlation Coefficient Skewed variables or outliers dealing by using Johnson transformation (J) [1] or Box-Cox Power Transformation (B) [1] . Factor Analysis with Principle Component Extraction Method [3] used to identify factors combination for multiple correlations. ra = Multiple Correlation Coefficient [2] rb = Canonical Correlation Coefficient [2] [1] Minitab 15 Program [2] statistiXL 1.8 Program [3] XLSTAT Program Significant levels : P*<0.05, P**<0.01, P***<0.001 Note: IR = insulin resistance; BMI = body mass index; WHR = waist-to-hip ratio; BP = blood pressure; NA = not applicable Table 3 The correlation of the insulin resistance indexes. For descriptive purposes, the sign of correlation coefficient (+/-) are presented using untransformed variables. For hypothesis testing purposes, the values of correlation coefficient (r) is presented using transformed variables. Skewed variables or outliers dealing by using Johnson transformation (J) [1] or Box-Cox Power Transformation (B) [1] . ra = Pearson Product Moment Correlation Coefficient (P) / Spearman's Rho Rank Correlation Coefficient (S) [2] rb = Partial Correlation Coefficient using 10,000 Stratified Bootstrap Samples with Bias Corrected and Accelerated 95% CI [2] (multiple testing bias corrections with controlling for covariate ages and stratified ethnics, T2DM and MS status) rc = Multiple Correlation Coefficient Table 4 The sensitivity and specificity of the insulin resistance indexes. . ANCOVA Test [2] in General Linear Model was used with adjustment the covariate effect of ages and . ANCOVA Test 
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Methods
Subjects. All subjects were native to Malaysia. The ages for all subjects were restricted to 40-70 years old and males in gender for the homogeneity of the subjects purposes. The subjects comprised three primary ethnic groups of Malaysian subjects which were Malay, Chinese and Indian. All the subjects were from the University Malaya Medical Centre (UMMC). The study design used was randomized case-control study. Ethical clearance (612.17) to undertake this study was obtained from the UMMC Ethics Committee and informed consent was obtained from each subject. Each subject received a detailed questionnaire about the personal and family disease history followed by the demographic data measurement.
The subjects classify into three main groups which were controls, type 2 diabetes mellitus (T2DM) and metabolic syndrome (MS Serum adiponectin and resistin levels measurement. Serum adiponectin levels were determined using the AssayMax Human Adiponectin ELISA Kit (AssayPro, USA) while serum resistin levels were detected using the AssayMax Human Resistin Elisa Kit (AssayPro, USA). For the adiponectin assayed, the intra-assay and inter-assay coefficients of variation were 4.1% and 7.2% respectively with a sensitivity of 0.5ng/ml.
Meanwhile, the intra-assay and inter-assay coefficients of variation were 4.0% and 7.2%
respectively with a sensitivity of <100pg/mL for the resistin assayed.
Other insulin resistance risk factors measurement. The other biochemical parameters including serum fasting insulin, total cholesterol, LDL cholesterol 34 , HDL cholesterol, triglycerides, plasma glucose and whole blood HbA1C levels were tested.
The clinical parameters including the blood pressure, body mass index (BMI), waist, and waist-to-hip ratio (WHR) also were measured and calculated. 
